The bill amends existing Louisiana law regarding prenatal care by establishing new requirements for testing pregnant women for HIV, syphilis, chlamydia, and gonorrhea. It mandates that primary healthcare providers conduct HIV and syphilis blood tests during a woman's initial prenatal visit in the first trimester and again in the third trimester. Additionally, it requires testing for chlamydia and gonorrhea at the first prenatal visit, with follow-up testing in the third trimester if necessary. The bill also clarifies that all testing must be considered a medically necessary covered service by health insurance providers, prohibiting prior authorization or utilization management requirements for these tests.

Furthermore, the bill introduces a new section that requires licensed healthcare providers to screen pregnant women for substance use disorder during the first trimester or at the first examination after confirming pregnancy, using a validated verbal screening tool. If a provider determines that a woman is at risk for substance use disorder, they must refer her for appropriate treatment. This comprehensive approach aims to enhance the health and safety of pregnant women and their babies by ensuring timely and necessary screenings and interventions.

Statutes affected:
SB174 Original:
SB174 Engrossed:
SB174 Reengrossed:
SB174 Enrolled:
SB174 Act 437: